Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Promimic ABFRA:B0T +4.00%68 Days Payable is 338.93 as of Mar. 2026, which is 89% below its 10-year median of 3,096.66. GuruFocus rates FRA:B0T with a GF Score™ of 68/100 and a GF Value™ of €2.69. The stock has 2 warning signs investors should review. Among 796 Medical Devices & Instruments companies, Promimic AB ranks better than 95.23% on this metric.
The historical rank and industry rank for Promimic AB's Days Payable or its related term are showing as below:
FRA:B0T'
s Days Payable Range Over the Past 10 Years
Min: 808.16 Med: 3096.66 Max: 6826.51
Current: 808.16
During the past 7 years, Promimic AB's highest Days Payable was 6826.51. The lowest was 808.16. And the median was 3096.66.
FRA:B0T's Days Payable is ranked better than 95.23% of 796
companies
in the Medical Devices & Instruments industry
Industry Median: 67.97
vs FRA:B0T: 808.16
Promimic AB's Days Payable
increased
from Mar. 2025 (0.00) to Mar. 2026 (338.93).
It may suggest that Promimic ABdelayed paying its suppliers.
Promimic AB Days Payable Related Terms
Promimic AB Days Payable Historical Data
* Premium members only.
The historical data trend for Promimic AB's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Promimic AB's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Promimic AB Days Payable vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Promimic AB's Days Payable distribution charts can be found below:
* The bar in red indicates where Promimic AB's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Promimic AB's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Promimic AB (FRA:B0T) has a Days Payable of 338.93 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Promimic AB and its competitors. This is 89% below median its historical median of 3,096.66. Over the past decade, Promimic AB's Days Payable has ranged from 808.16 to 6,826.51. According to the industry distribution chart, Promimic AB ranks #38 out of 796 companies in the Medical Devices & Instruments industry, placing it in the top 4.8%.
Is Promimic AB's Days Payable too high?
Promimic AB's current Days Payable of 338.93 is 89% below median its 10-year median of 3,096.66. Over the past 10 years, this metric has ranged from a low of 808.16 to a high of 6,826.51. The Medical Devices & Instruments industry median Days Payable is 67.97. Promimic AB's value of 338.93 is 398.6% above this industry median. Based on the distribution chart, Promimic AB ranks #38 out of 796 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Promimic AB has a GF Score™ of 68/100, reflecting its overall financial health beyond just this single metric.
How does Promimic AB's Days Payable compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Promimic AB ranks #38 out of 796 companies for Days Payable. This places Promimic AB in the top 5% of its industry — outperforming the majority of peers. The industry median Days Payable is 67.97. Promimic AB's value of 338.93 is 398.6% above this benchmark. Historically, Promimic AB's own Days Payable has ranged from 808.16 to 6,826.51 over the past decade. While the company's 10-year median is 3,096.66 vs. the industry median of 67.97, Promimic AB has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Medical Devices & Instruments company?
The median Days Payable among Medical Devices & Instruments companies is 67.97, based on 796 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Promimic AB's current Days Payable of 338.93 is 398.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Promimic AB and its competitors. For the Medical Devices & Instruments industry, the median Days Payable is 67.97 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Promimic AB's current Days Payable is 338.93, which is 89% below median its own 10-year median of 3,096.66. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Promimic AB stock overvalued right now?
Promimic AB (FRA:B0T) has a current Days Payable of 338.93. The stock's GF Value™ is €2.69, compared to a current price of €0.91 — trading 66.2% below its estimated fair value. The current Days Payable is 338.93, which is 89% below median its 10-year median of 3,096.66 and 398.6% above the Medical Devices & Instruments industry median of 67.97. Promimic AB's overall GF Score™ is 68/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Promimic AB (FRA:B0T), the current Days Payable is 338.93 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Promimic AB (FRA:B0T) Overvalued in 2026?
Based on GuruFocus' analysis, Promimic AB stock appears to be undervalued.
The current stock price of €0.91 is trading 66.2% below its estimated GF Value™ of €2.69.
Key valuation signals for FRA:B0T:
Days Payable: 338.93 (89% below median its 10-year median of 3,096.66)
GF Value™: €2.69 vs. price of €0.91 (66.2% below fair value)
Industry Position: 398.6% above the Medical Devices & Instruments median (#38 of 796)
No single metric tells the full story. See the FRA:B0T stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:B0T has been successfully added to your 
